Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking

Antibodies play an increasing pivotal role in both basic research and the biopharmaceutical sector, therefore technology for characterizing and improving their properties through rational engineering is desirable. This is a difficult task thought to require high-resolution x-ray structures, which are not always available. We, instead, use a combination of solution NMR epitope mapping and computational docking to investigate the structure of a human antibody in complex with the four Dengue virus serotypes. Analysis of the resulting models allows us to design several antibody mutants altering its properties in a predictable manner, changing its binding selectivity and ultimately improving its ability to neutralize the virus by up to 40 fold. The successful rational design of antibody mutants is a testament to the accuracy achievable by combining experimental NMR epitope mapping with computational docking and to the possibility of applying it to study antibody/pathogen interactions.

[1]  C. Midgley,et al.  Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.

[2]  Hugues Bedouelle,et al.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.

[3]  John McCafferty,et al.  Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.

[4]  Ya-jun Guo,et al.  A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein , 2011, PloS one.

[5]  Luca Varani,et al.  Computational Docking of Antibody-Antigen Complexes, Opportunities and Pitfalls Illustrated by Influenza Hemagglutinin , 2011, International journal of molecular sciences.

[6]  Jens Meiler,et al.  ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. , 2011, Methods in enzymology.

[7]  Cameron P Simmons,et al.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.

[8]  Luigi Calzolai,et al.  Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking. , 2010, Journal of molecular biology.

[9]  M. Accavitti-Loper,et al.  Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. , 2009, Virology.

[10]  Woonghee Lee,et al.  PINE-SPARKY: graphical interface for evaluating automated probabilistic peak assignments in protein NMR spectroscopy , 2009, Bioinform..

[11]  Jeffrey J. Gray,et al.  RosettaAntibody: antibody variable region homology modeling server , 2009, Nucleic Acids Res..

[12]  Jeffrey J. Gray,et al.  Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. , 2008, Journal of molecular biology.

[13]  Paolo Marcatili,et al.  PIGS: automatic prediction of antibody structures , 2008, Bioinform..

[14]  A. Barrett,et al.  NMR assignments of the sylvatic dengue 1 virus envelope protein domain III , 2008, Biomolecular NMR assignments.

[15]  Richard J Kuhn,et al.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.

[16]  H. Lei,et al.  Solution structure and neutralizing antibody binding studies of domain III of the dengue‐2 virus envelope protein , 2008, Proteins.

[17]  David M. Kranz,et al.  Solution mapping of T cell receptor docking footprints on peptide-MHC , 2007, Proceedings of the National Academy of Sciences.

[18]  Gregory D. Gromowski,et al.  Solution structure of the envelope protein domain III of dengue-4 virus. , 2007, Virology.

[19]  R. Stevens,et al.  Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin , 2007, Nature Biotechnology.

[20]  A. Barrett,et al.  NMR assignment of the Dengue 4 virus envelope protein domain III , 2006, Journal of biomolecular NMR.

[21]  Yi Liu,et al.  RosettaDesign server for protein design , 2006, Nucleic Acids Res..

[22]  Y. Modis,et al.  Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein , 2005, Journal of Virology.

[23]  Timothy S Baker,et al.  Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.

[24]  K. Stiasny,et al.  Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.

[25]  Jeffrey J. Gray,et al.  Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. , 2003, Journal of molecular biology.

[26]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Dominguez,et al.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.

[28]  S. Halstead,et al.  Neutralization and antibody-dependent enhancement of dengue viruses. , 2003, Advances in virus research.

[29]  D. Vaughn,et al.  Dengue: an escalating problem , 2002, BMJ : British Medical Journal.

[30]  J. Roehrig,et al.  Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.

[31]  L. Kay,et al.  The NMR structure of the 38 kDa U1A protein – PIE RNA complex reveals the basis of cooperativity in regulation of polyadenylation by human U1A protein , 2000, Nature Structural Biology.

[32]  A Tramontano,et al.  Antibody modeling: implications for engineering and design. , 2000, Methods.

[33]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[34]  M. Saeed,et al.  Dengue and Dengue Hemorrhagic Fever , 2015 .